Filed: 5/15/2026ACC: 0001999371-26-010896
📋 What this filing means
FIRST LIGHT ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $1.12B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$1.12B
Total AUM (reported)
78.69M
Total Shares
Allocation by class
COMMON STOCKS$1.12B100.0%
Portfolio Concentration
Top 3$327.06M29.3%
4–10$341.01M30.6%
11–25$342.49M30.7%
Rest$105.32M9.4%
Top 3 weight
29.3%
Top 10 weight
59.9%
Voting Authority Distribution
Total shares with voting rights: 78.69M
Sole
Full voting authority
78.69M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
AXOGEN INC
SOLEShares4M
TypeSH
Market value$132.61M
11.88%
Sole
4M
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC
SOLEShares980.76K
TypeSH
Market value$122.25M
10.96%
Sole
980.76K
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares9.73M
TypeSH
Market value$72.20M
6.47%
Sole
9.73M
Shared
0.00
None
0.00
SI-BONE INC
SOLEShares5.35M
TypeSH
Market value$67.61M
6.06%
Sole
5.35M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS LIMITED
SOLEShares1.56M
TypeSH
Market value$62.00M
5.56%
Sole
1.56M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares576.68K
TypeSH
Market value$48.54M
4.35%
Sole
576.68K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares3.19M
TypeSH
Market value$44.35M
3.97%
Sole
3.19M
Shared
0.00
None
0.00
TWIST BIOSCIENCE CORPORATION
SOLEShares878.85K
TypeSH
Market value$41.76M
3.74%
Sole
878.85K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$39.58M
3.55%
Sole
1.09M
Shared
0.00
None
0.00
908 DEVICES INC
SOLEShares6.07M
TypeSH
Market value$37.16M
3.33%
Sole
6.07M
Shared
0.00
None
0.00
NEUROPACE INC
SOLEShares2.46M
TypeSH
Market value$32.35M
2.90%
Sole
2.46M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$31.56M
2.83%
Sole
1M
Shared
0.00
None
0.00
ANAPTYS BIO INC
SOLEShares565.43K
TypeSH
Market value$31.36M
2.81%
Sole
565.43K
Shared
0.00
None
0.00
SIMULATIONS PLUS INC
SOLEShares2.63M
TypeSH
Market value$31.12M
2.79%
Sole
2.63M
Shared
0.00
None
0.00
GUARDANT HEALTH
SOLEShares280.30K
TypeSH
Market value$25.89M
2.32%
Sole
280.30K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares1.31M
TypeSH
Market value$25.20M
2.26%
Sole
1.31M
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares729.52K
TypeSH
Market value$20.81M
1.87%
Sole
729.52K
Shared
0.00
None
0.00
TRISALUS LIFE SCIENCES INC
SOLEShares5.07M
TypeSH
Market value$20.27M
1.82%
Sole
5.07M
Shared
0.00
None
0.00
TECTONIC THERAPEUTICS INC
SOLEShares647.74K
TypeSH
Market value$20.02M
1.79%
Sole
647.74K
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES
SOLEShares168.12K
TypeSH
Market value$19.84M
1.78%
Sole
168.12K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares732.86K
TypeSH
Market value$17.61M
1.58%
Sole
732.86K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HOLDINGS
SOLEShares307.74K
TypeSH
Market value$17.47M
1.57%
Sole
307.74K
Shared
0.00
None
0.00
HEALTH CATALYST INC
SOLEShares12.88M
TypeSH
Market value$16.36M
1.47%
Sole
12.88M
Shared
0.00
None
0.00
OMNICELL INC
SOLEShares489.85K
TypeSH
Market value$16.35M
1.47%
Sole
489.85K
Shared
0.00
None
0.00
KORU MEDICAL SYSTEMS INC
SOLEShares3.77M
TypeSH
Market value$16.28M
1.46%
Sole
3.77M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AXOGEN INCSOLE | Common Stocks | 4M | SH | $132.61M 11.88% | 4M | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INCSOLE | Common Stocks | 980.76K | SH | $122.25M 10.96% | 980.76K | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | Common Stocks | 9.73M | SH | $72.20M 6.47% | 9.73M | 0.00 | 0.00 |
SI-BONE INCSOLE | Common Stocks | 5.35M | SH | $67.61M 6.06% | 5.35M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS LIMITEDSOLE | Common Stocks | 1.56M | SH | $62.00M 5.56% | 1.56M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | Common Stocks | 576.68K | SH | $48.54M 4.35% | 576.68K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | Common Stocks | 3.19M | SH | $44.35M 3.97% | 3.19M | 0.00 | 0.00 |
TWIST BIOSCIENCE CORPORATIONSOLE | Common Stocks | 878.85K | SH | $41.76M 3.74% | 878.85K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INCSOLE | Common Stocks | 1.09M | SH | $39.58M 3.55% | 1.09M | 0.00 | 0.00 |
908 DEVICES INCSOLE | Common Stocks | 6.07M | SH | $37.16M 3.33% | 6.07M | 0.00 | 0.00 |
NEUROPACE INCSOLE | Common Stocks | 2.46M | SH | $32.35M 2.90% | 2.46M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | Common Stocks | 1M | SH | $31.56M 2.83% | 1M | 0.00 | 0.00 |
ANAPTYS BIO INCSOLE | Common Stocks | 565.43K | SH | $31.36M 2.81% | 565.43K | 0.00 | 0.00 |
SIMULATIONS PLUS INCSOLE | Common Stocks | 2.63M | SH | $31.12M 2.79% | 2.63M | 0.00 | 0.00 |
GUARDANT HEALTHSOLE | Common Stocks | 280.30K | SH | $25.89M 2.32% | 280.30K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | Common Stocks | 1.31M | SH | $25.20M 2.26% | 1.31M | 0.00 | 0.00 |
ATRICURE INCSOLE | Common Stocks | 729.52K | SH | $20.81M 1.87% | 729.52K | 0.00 | 0.00 |
TRISALUS LIFE SCIENCES INCSOLE | Common Stocks | 5.07M | SH | $20.27M 1.82% | 5.07M | 0.00 | 0.00 |
TECTONIC THERAPEUTICS INCSOLE | Common Stocks | 647.74K | SH | $20.02M 1.79% | 647.74K | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIESSOLE | Common Stocks | 168.12K | SH | $19.84M 1.78% | 168.12K | 0.00 | 0.00 |
SEPTERNA INCSOLE | Common Stocks | 732.86K | SH | $17.61M 1.58% | 732.86K | 0.00 | 0.00 |
ESTABLISHMENT LABS HOLDINGSSOLE | Common Stocks | 307.74K | SH | $17.47M 1.57% | 307.74K | 0.00 | 0.00 |
HEALTH CATALYST INCSOLE | Common Stocks | 12.88M | SH | $16.36M 1.47% | 12.88M | 0.00 | 0.00 |
OMNICELL INCSOLE | Common Stocks | 489.85K | SH | $16.35M 1.47% | 489.85K | 0.00 | 0.00 |
KORU MEDICAL SYSTEMS INCSOLE | Common Stocks | 3.77M | SH | $16.28M 1.46% | 3.77M | 0.00 | 0.00 |
Page 1 of 2